Mankind Pharma acquires Bharat Serums from Advent International for ₹13,630 crore. Learn More
Qualified Institutional Placement - PD

PLEASE READ THIS NOTICE CAREFULLY 

THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.

Investors should read the Placement Document and seek professional advice before taking any action.  Kotak Mahindra Capital Company Limited (“Kotak”) and IIFL Capital Services Limited (“IIFL”) do not accept any liability whatsoever direct or indirect that may arise from the use of the information contained in the Placement Document.

IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing. 

The following disclaimer applies to the Placement Document of Mankind Pharma Limited (the “Company”) dated December 19, 2024 filed with the Securities and Exchange Board of India (“SEBI”) (the “Placement Document”) hosted on this website in connection with the public offering of securities (the “Offer”). Kotak and IIFL are each associated with the Offer as a Book Running Lead Manager (“BRLM”; together, the “BRLMs”). You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Placement Document. By accessing the Placement Document, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.

The information in this portion of our website, including the Placement Document, is not for publication or distribution, directly or indirectly, in or into the United States. Please note that because of restrictions imposed by law on soliciting offers of securities in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. The contents of the Placement Document are for your information only and you acknowledge that access to the Placement Document is intended for use by you only and you agree not to forward the Placement Document on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. No part of the contents of the Placement Document shall be copied or duplicated in any form by any means, or redistributed. 

You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither the BRLMs nor any of their  affiliates, or their respective directors, officers and employees (together, the "Affiliates"), accept any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data. 

The Placement Document does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the BRLMs or any of their Affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. 

The equity shares of the Company (the “Equity Shares”) have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States absent registration under the U.S. Securities Act or except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold (a) in the United States only to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) pursuant to Section 4(a) of the U.S. Securities Act, and (b) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales are made. There will be no public offering of the Equity Shares in the United States.

Any person into whose possession the Placement Document comes is required to inform himself or herself about and to observe any such restrictions. Neither the BRLMs nor any of their Affiliates are soliciting any action based on any information contained on this website, including the Placement Document, and such information should not be construed as an offer to sell or the solicitation of an offer to buy or subscribe for any securities. Potential investors should not rely on the Placement Document for any investment decision. Any decision on whether to invest in the securities described in the placement document may only be made after such placement document has been filed with the RoC and must be made solely on the basis of such placement document. As there may be material changes in the placement document as compared to the preliminary placement document, potential investors should not rely on the preliminary placement document. Any potential investor should note that investment in the securities involves a high degree of risk. For details, potential investors should refer to the Placement Document, which may be filed by the Company with the relevant Registrar of Companies, including the section titled “Risk Factors”. 

Neither the BRLMs nor any of their Affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. Neither the BRLMs nor any of their Affiliates represent that the content of the Placement Document is accurate or complete. The BRLMs and their Affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Placement Document beyond the date of the Placement Document. The information contained in the Placement Document is as of the date thereof and neither the BRLMs or their Affiliates are under any obligation to update the Placement Document to reflect circumstances arising after the date thereof.

The BRLMs and their Affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the BRLMs, nor any of their Affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, or inability to access or use of, the website or these materials.

Please note that forms downloaded and used for subscription to the Offer in contravention of the above will be rejected with no recourse to the BRLMs, the Company, or any of their respective Affiliates.

If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.


To access this information, you must confirm by pressing on the button marked “I Confirm” that, at the time of access you are located in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”. 

The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.